List of works - Cátia Teixeira

"Clicking" an Ionic Liquid to a Potent Antimicrobial Peptide: On the Route towards Improved Stability

scientific article published on 26 August 2020

"Recycling" classical drugs for malaria

scientific article published on 20 October 2014

2D and 3D QSAR studies of diarylpyrimidine HIV-1 reverse transcriptase inhibitors

article

A Quinacrine Analogue Selective Against Gastric Cancer Cells: Insight from Biochemical and Biophysical Studies

scientific article published on 14 November 2016

Building on Surface-Active Ionic Liquids for the Rescuing of the Antimalarial Drug Chloroquine

scientific article published on 27 July 2020

Cinnamic acid/chloroquinoline conjugates as potent agents against chloroquine-resistant Plasmodium falciparum

scientific article published on 29 June 2012

Design, synthesis, and biological evaluation of N-carboxyphenylpyrrole derivatives as potent HIV fusion inhibitors targeting gp41

scientific article published on December 2008

Development of Plasmodium falciparum protease inhibitors in the past decade (2002-2012).

scientific article published on January 2013

Docking and 3D-QSAR studies of BMS-806 analogs as HIV-1 gp120 entry inhibitors

scientific article published on 28 March 2009

Effects of novel triple-stage antimalarial ionic liquids on lipid membrane models

scientific article published on 3 July 2017

Falcipains, Plasmodium falciparum cysteine proteases as key drug targets against malaria.

scientific article published on January 2011

Flexible computational docking studies of new aminoglycosides targeting RNA 16S bacterial ribosome site

scientific article published on 22 October 2007

ImmunoPEGliposomes for the targeted delivery of novel lipophilic drugs to red blood cells in a falciparum malaria murine model

scientific article

In Vitro Evaluation of Five Antimicrobial Peptides against the Plant Pathogen Erwinia amylovora

scientific article published in 2021

In vitro efficiency of 9-(N-cinnamoylbutyl)aminoacridines against blood- and liver-stage malaria parasites

scientific article

Is the conformational flexibility of piperazine derivatives important to inhibit HIV-1 replication?

scientific article

Molecular docking and 3D-quantitative structure activity relationship analyses of peptidyl vinyl sulfones: Plasmodium Falciparum cysteine proteases inhibitors.

scientific article published on 24 July 2011

Molecular modeling studies of N-substituted pyrrole derivatives--potential HIV-1 gp41 inhibitors

scientific article published on 28 January 2008

N-Cinnamoylation of Antimalarial Classics: Effects of Using Acyl Groups Other than Cinnamoyl toward Dual-Stage Antimalarials

scientific article published on 2 June 2015

N-cinnamoylated aminoquinolines as promising antileishmanial agents.

scientific article published on 05 August 2013

N-cinnamoylated chloroquine analogues as dual-stage antimalarial leads

scientific article published on 8 January 2013

N-cinnamoylation of antimalarial classics: quinacrine analogues with decreased toxicity and dual-stage activity

scientific article published on 27 December 2013

Novel cinnamic acid/4-aminoquinoline conjugates bearing non-proteinogenic amino acids: towards the development of potential dual action antimalarials

scientific article published on 28 May 2012

PRIMACINS, N-cinnamoyl-primaquine conjugates, with improved liver-stage antimalarial activity

Recycling antimalarial leads for cancer: Antiproliferative properties of N-cinnamoyl chloroquine analogues

scientific article published on 21 October 2013

Striking HIV-1 Entry by Targeting HIV-1 gp41. But, Where Should We Target?

scientific article published on 19 January 2016

Synthesis, characterization and catalytic studies of bis(chloro)dioxomolybdenum(VI)-chiral diimine complexes

Toward the discovery of inhibitors of babesipain-1, a Babesia bigemina cysteine protease: in vitro evaluation, homology modeling and molecular docking studies

scientific article

Viral surface glycoproteins, gp120 and gp41, as potential drug targets against HIV-1: brief overview one quarter of a century past the approval of zidovudine, the first anti-retroviral drug.

scientific article published on 03 February 2011

Wound-Healing Peptides for Treatment of Chronic Diabetic Foot Ulcers and Other Infected Skin Injuries

scientific article

List of works by Cátia Teixeira

"Clicking" an Ionic Liquid to a Potent Antimicrobial Peptide: On the Route towards Improved Stability

"Recycling" classical drugs for malaria

2D and 3D QSAR studies of diarylpyrimidine HIV-1 reverse transcriptase inhibitors

A Quinacrine Analogue Selective Against Gastric Cancer Cells: Insight from Biochemical and Biophysical Studies

Building on Surface-Active Ionic Liquids for the Rescuing of the Antimalarial Drug Chloroquine

Cinnamic acid/chloroquinoline conjugates as potent agents against chloroquine-resistant Plasmodium falciparum

Design, synthesis, and biological evaluation of N-carboxyphenylpyrrole derivatives as potent HIV fusion inhibitors targeting gp41

Development of Plasmodium falciparum protease inhibitors in the past decade (2002-2012).

Docking and 3D-QSAR studies of BMS-806 analogs as HIV-1 gp120 entry inhibitors

Effects of novel triple-stage antimalarial ionic liquids on lipid membrane models

Falcipains, Plasmodium falciparum cysteine proteases as key drug targets against malaria.

Flexible computational docking studies of new aminoglycosides targeting RNA 16S bacterial ribosome site

ImmunoPEGliposomes for the targeted delivery of novel lipophilic drugs to red blood cells in a falciparum malaria murine model

In Vitro Evaluation of Five Antimicrobial Peptides against the Plant Pathogen Erwinia amylovora

In vitro efficiency of 9-(N-cinnamoylbutyl)aminoacridines against blood- and liver-stage malaria parasites

Is the conformational flexibility of piperazine derivatives important to inhibit HIV-1 replication?

Molecular docking and 3D-quantitative structure activity relationship analyses of peptidyl vinyl sulfones: Plasmodium Falciparum cysteine proteases inhibitors.

Molecular modeling studies of N-substituted pyrrole derivatives--potential HIV-1 gp41 inhibitors

N-Cinnamoylation of Antimalarial Classics: Effects of Using Acyl Groups Other than Cinnamoyl toward Dual-Stage Antimalarials

N-cinnamoylated aminoquinolines as promising antileishmanial agents.

N-cinnamoylated chloroquine analogues as dual-stage antimalarial leads

N-cinnamoylation of antimalarial classics: quinacrine analogues with decreased toxicity and dual-stage activity

Novel cinnamic acid/4-aminoquinoline conjugates bearing non-proteinogenic amino acids: towards the development of potential dual action antimalarials

PRIMACINS, N-cinnamoyl-primaquine conjugates, with improved liver-stage antimalarial activity

Recycling antimalarial leads for cancer: Antiproliferative properties of N-cinnamoyl chloroquine analogues

Striking HIV-1 Entry by Targeting HIV-1 gp41. But, Where Should We Target?

Synthesis, characterization and catalytic studies of bis(chloro)dioxomolybdenum(VI)-chiral diimine complexes

Toward the discovery of inhibitors of babesipain-1, a Babesia bigemina cysteine protease: in vitro evaluation, homology modeling and molecular docking studies

Viral surface glycoproteins, gp120 and gp41, as potential drug targets against HIV-1: brief overview one quarter of a century past the approval of zidovudine, the first anti-retroviral drug.

Wound-Healing Peptides for Treatment of Chronic Diabetic Foot Ulcers and Other Infected Skin Injuries